ROBINA BOKHARI: Open Payments
NPI 1588760706 · SOMERSET, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 66 payments from 11 companies in 2025. Trend: 2023 $1,340 · 2024 $995 · 2025 $1,261
Food & beverage: $1,261
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 15 | $328 |
| Otsuka America Pharmaceutical, Inc. | 20 | $302 |
| Lundbeck LLC | 7 | $162 |
| Vanda Pharmaceuticals Inc. | 9 | $155 |
| ABBVIE INC. | 4 | $83 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| Almatica Pharma LLC | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: ARISTADA, REXULTI, FANAPT, ABILIFY ASIMTUFII, VRAYLAR, Auvelity, COBENFY, ABILIFY MAINTENA.
Industry payments across KY — which companies pay providers there.
